FDA successfully completed inspection of Derivados Quimicos sau

Infa Group is pleased to announce that the US Food and Drug Administration (FDA) has successfully completed the inspection of the Spanish active pharmaceutical ingredient (API) and intermediates manufacturing facility Derivados Quimicos.

The FDA inspected Derivados Quimicos  from October 19 to 22, 2015 and found the site to be compliant with the principles and guidelines of Good Manufacturing Practices with only one minor  483 observation.

Daniele Cardoso, Chairman of Infa Group, commented:  ” This is the third and last successful FDA inspection this year with positively completed inspections earlier this spring at our Italian manufacturing units Sifavitor and Labochim; proudly confirming our commitment to maintain high quality standards at all our manufacturing sites.”